The Global Quest Initiative

HIF is proud to support a national research study into medicinal cannabis - The Global QUEST Initiative, in partnership with Little Green Pharma. 

The Global QUEST initiative will investigate the quality of life and health economic impact of medicinal cannabis in patients with chronic conditions across Australia through a series of online questionnaires.

Learn More

 
 

Why should I be involved?

  • Access to medicinal cannabis products

    Access to medicinal cannabis at a discounted cost

  • Access to an experienced QUEST doctor

    Or assistance in enrolling your doctor in the Global QUEST Initiative (if your doctor is willing to participate)

  • Participate from the comfort of your
    own home

    The opportunity to participate in the study via an online questionnaire

  • Contribute to a world-first longitudinal study

    To better understand the impacts of medicinal cannabis on quality of life

HIF Members Save More.

HIF will pay a benefit towards the medicinal cannabis products that are part of the Global QUEST Initiative, if your Extras cover includes Pharmacy. 

Benefits are payable under your Pharmacy Limit and are subject to individual policy limits and waiting periods. 

Please refer to your policy factsheets for details on your eligibility and individual benefit.

Who can participate?

To be eligible to take part in the Global QUEST initiative you must be:

  • 18+ years of age and living in Australia
  • suffering from a chronic condition with symptoms that have lasted for three months or more
  • eligible for medicinal cannabis as a form of treatment
  • have access to the internet or a smartphone
  • are able to complete digital questionnaires in English; and
  • are able to provide informed consent
  • have not taken any type of cannabis therapy for four weeks before enrolling in the study
  • Eligibility for this study and medicinal cannabis treatment will ultimately be determined by a consulting doctor based on your individual clinical circumstances.

    If you are a HIF member and meet the outlined criteria, you may be eligible to participate. Simply visit the QUEST website and click on the ‘Am I eligible?’ button to take part in the screening questionnaire. (Currently recruiting, for more details visit the QUEST website).

What's involved in the study?

The Global QUEST initiative will measure quality of life and health economic impacts of medicinal cannabis through a series of online questionnaires. Participants will be required to complete questionnaires before starting their medicinal cannabis treatment, two weeks and then one month after starting treatment, three-monthly for the rest of the year and six-monthly until the end of their study participation.

The questionnaires, which take between 20-30 minutes, can be completed from home, or anywhere with an internet connection. As part of a normal treatment regime with medicinal cannabis, patients will need to consult their doctor periodically to discuss their results, receive additional scripts, and to ensure continuity of care.

More about the study

Understanding that some patients may have mobility issues, QUEST has participating doctors who can offer telehealth appointments for members who are unable to leave their home.

Members can participate in the study for up to 12 months. During this time, members will be required to pay for their own medication and doctor consult visits.

Please note: dosage requirements will be determined by your prescribing doctor and will vary from patient to patient.

Participation is voluntary and participants can ‘opt-out’ at any time.

 
 

How can I get involved?

Simply enrol in 3 easy steps:

  • 1

    Check your eligibility

    Take a quick 60-second screening questionnaire online 

  • 2

    Register your interest 

    Sign up to the Global Quest Initiative by registering on their website

  • 3

    Book an appointment

    With a registered QUEST doctor or request your doctor to become part of the initiative

Once your doctor confirms you are eligible you will receive a study invitation by email. For more information please click here or an explanatory video is available on their patient's page here.  
Have more questions? Check out the handy FAQ's below or visit Quest's website.

 

What if I'm interested in accessing medicinal cannabis but not via The Global QUEST Initiative?

HIF will pay a benefit towards medicinal cannabis products if your Extras cover includes Pharmacy. For more information about Medicinal Cannabis and Treatment Access through HIF Extras policies please visit our Medicinal Cannabis FAQs page.

To access Medicinal Cannabis as an alternative treatment option, please visit your doctor to discuss your options. The following guide may be of assistance before your consult, Simple Steps to Access.  

If for any reason your doctor isn't able to help you with your eligibility, you can contact Little Green Pharma on 1300 703 999 or email info@littlegreenpharma.com and they can help find a doctor knowledgeable about medicinal cannabis, near you.

Frequently Asked Questions

 

What is The Global QUEST Initiative?

The Global QUEST Initiative is a quality of life study that is being conducted by researchers at Curtin University. This observational study is investigating quality of life and health economic impacts for Australians accessing medicinal cannabis in relation to a chronic disease.

Who can participate in the study?

QUEST is seeking eligible patients who are:

  • 18+ years of age and living in Australia
  • suffering from a chronic condition with symptoms that have lasted for three months or more
  • eligible for medicinal cannabis as a form of treatment
  • able to complete digital questionnaires in English
  • able to provide informed consent
  • have access to the internet or a smart phone and
  • have not taken any type of prescription cannabis therapy for four weeks before enrolling in the study

Eligibility for this study and medicinal cannabis treatment will ultimately be determined by your consulting doctor based on your individual circumstances.  

What are the benefits for participants?

Benefits for participants include:

  • Discounted cost of medications for up to 12 months
    - from $135 per 50ml bottle or $130 per 10g sachet (including delivery fee).
  • Access to a doctor who is experienced in prescribing medicinal cannabis (if a QUEST enrolled doctor is chosen) or assistance in enrolling your doctor in QUEST (if your doctor is willing to participate).
  • The opportunity to participate in a non-invasive, online study from the comfort of your home.

What's involved for participants?

The Global QUEST Initiative will measure its participants outcomes through a series of online questionnaires. Participants will be required to complete questionnaires before starting medicinal cannabis treatment, two weeks after starting treatment, then every one to two months for up to one year.

Questionnaires, which take between 20-30 minutes, can be completed from home, or anywhere with an internet connection. As part of a normal treatment regime with medicinal cannabis, patients will need to consult their doctor periodically to discuss their results, receive additional scripts, and to ensure continuity of care.

Understanding that some patients may have mobility issues, The Global QUEST Initiative has worked with some participating doctors to offer telehealth appointments for patients, and medications for this trial will be sent directly to the patient's home.

How long can I join the study for?

You can join the study for up to 12-months. Participation is voluntary and you can ‘opt-out’ at any time.

How much will my medication cost while on the study?

You will be required to pay for your own medication for the duration of the study. Medication will be available from The Global QUEST Initiative at a subsidised cost from only $135 per 50ml bottle or $130 per 10g sachet (including delivery fee).

HIF will pay a benefit towards the medicinal cannabis products that are part of the Global QUEST Initiative, if your Extras cover includes Pharmacy. 

Benefits are payable under your Pharmacy Limit and are subject to individual policy limits and waiting periods. 

Please refer to your policy factsheets for details on your eligibility and individual benefit.

You will be prompted to pay for the product before it is distributed. Payment can be made by credit or debit card via a secure payment gateway.

Please note dosage requirements will be determined by your prescribing doctor and will differ from patient to patient.

Standard doctor consult fees also apply. If you choose to visit a QUEST doctor you will be able to check their consult fees on the website’s doctor directory before booking a consult.

What is the study looking to accomplish?

Patients accessing medicinal cannabis generally have a range of conditions and symptoms that impact their quality of life. While length of life is easy to measure, quality of life is more subjective, but it can be measured by asking patients questions about different aspects of their health such as their mobility, functionality, pain, discomfort, anxiety and depression.

This clinical study sets out to better understand and measure how these conditions and symptoms affect a patient’s quality of life over time while they are accessing medicinal cannabis as a treatment option and will do so through online questionnaires.

How can I enrol in the Global Quest Initiative?

To enrol in the study follow these three easy steps:

  1. Check your potential eligibility (take the 60 second screening survey online)
  2. Register your interest
  3. Book an appointment with a recruited QUEST doctor or request your usual doctor to become a part of the Global QUEST initiative.

After your doctor confirms you are eligible you will receive a study invitation by email.

For more information or to start your QUEST please click here

An explanatory video is available on the Patients page here

Frequently asked questions can be found here

What benefit does HIF provide for medicinal cannabis products?

HIF will pay a benefit towards medicinal cannabis products if your Extras cover includes Pharmacy. The benefits are payable from 9 September 2020.

Benefits are payable under your Pharmacy Limit and are subject to individual policy limits and waiting periods. 

Please refer to your policy factsheets for details on your eligibility and individual benefit.

Would you like to get in touch?

You’ll find the different ways to chat to us here

Connect with us on our socials